EUVIMEDEUVIMED entdecken
Crossref

Effects of oral-gastric treatment and family therapy on H. Pylori eradication and recurrence

Zhiqiang Chen, Fang Yuan, Chao Pan

Arab Journal of Gastroenterology · 2025

DOI: 10.1016/j.ajg.2025.08.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arab Journal of Gastroenterology, 2025. Verfasst von Zhiqiang Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Cangshan Hospital, The 900th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Fujian 365100,…. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Anti-Bacterial Agents, Proton Pump Inhibitors. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND STUDY AIMS: Helicobacter pylori (H. pylori) infections are notably difficult to eradicate due to high antibiotic resistance and frequent reinfection. This study evaluates the effectiveness of combining oral and gastric treatments with synchronized family therapy compared to standard therapy for H. pylori management. PATIENTS AND METHODS: Conducted at Cangshan Hospital of the 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, the study included 180 patients divided into three groups: standard triple therapy (Group A), triple therapy plus oral treatment (Group B), and triple therapy with oral treatment and synchronized family therapy (Group C). Eradication and recurrence were measured at 3 and 6 months using stool antigen tests and 14C-urea breath tests. RESULTS: Initial eradication rates were similar across the three groups. By 3 months, eradication rates reached 76.7 % in Group A, 86.7 % in Group B, and 93.3 % in Group C. At 6 months, these rates were 61.7 %, 66.7 %, and 90 %, respectively. Concurrently, recurrence rates at 6 months climbed to 33.9 % and 29.8 % in Groups A and B, respectively, but remained low at 5.3 % in Group C. CONCLUSION: The addition of synchronized family therapy significantly enhances long-term eradication and reduces recurrence rates, suggesting its potential for incorporation into standard H. pylori treatment protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsProton Pump InhibitorsFamily TherapyHumansFemaleMaleAdultMiddle AgedDrug Therapy, CombinationAdministration, OralRecurrenceAmoxicillinBreath TestsClarithromycinTreatment OutcomeMetronidazole

Stichwörter der Autor:innen

Family therapyHelicobacter pyloriOral treatmentRecurrenceSynchronized treatment

Substanzen

Anti-Bacterial AgentsProton Pump InhibitorsAmoxicillinClarithromycinMetronidazole

Autor:innen und Institutionen

  • Department of Stomatology, Cangshan Hospital, The 900th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Fujian 365100, China.
  • Department of Stomatology, Cangshan Hospital, The 900th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Fujian 365100, China. Electronic address: qq17777954870@163.com.

Zitieren

APA

Chen, Z., Yuan, F., & Pan, C. (2025). Effects of oral-gastric treatment and family therapy on H. Pylori eradication and recurrence. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2025.08.005

Vancouver

Chen Z, Yuan F, Pan C. Effects of oral-gastric treatment and family therapy on H. Pylori eradication and recurrence. Arab Journal of Gastroenterology. 2025. doi:10.1016/j.ajg.2025.08.005

BibTeX
@article{Chen2025,
  author = {Chen, Zhiqiang and Yuan, Fang and Pan, Chao},
  title = {Effects of oral-gastric treatment and family therapy on H. Pylori eradication and recurrence},
  journal = {Arab Journal of Gastroenterology},
  year = {2025},
  doi = {10.1016/j.ajg.2025.08.005}
}
Kostenlos starten →